NEW YORK (GenomeWeb) – Congenica announced today that it has raised £8 million ($10 million) after closing a round of Series B financing.

The British genomics company will use the proceeds from the round to invest in sales and marketing efforts for its Sapientia clinical genome analysis platform, as well as for R&D.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.